Koers Biohaven Pharmaceutical Holding Company Ltd.
Aandelen
BHVN
VGG111961055
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
54,69 USD | -4,09% | -3,94% | -63,97% |
04/03 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. : HC Wainwright handhaaft koopadvies | ZM |
01/03 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. : TD Cowen herhaalt koopadvies | ZM |
Omzet 2020 | 63,63 58,99 | Omzet 2021 | 462,51 428,78 | Marktkapitalisatie | 9,03 mld. 8,37 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -767 mln. -711 mln. | Nettowinst (verlies) 2021 | -847 mln. -785 mln. | EV/omzet 2020 | 87.534.473 x |
Nettoschuld 2020 | 432 mln. 401 mln. | Nettoschuld 2021 | 860 mln. 798 mln. | EV/omzet 2021 | 21.377.123 x |
K/w-verhouding 2020 |
-6,56
x | K/w-verhouding 2021 |
-10,5
x | Werknemers | 928 |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 90,13% |
1 dag | -4,09% | ||
Lopende maand | -63,97% | ||
Lopend jaar | -63,97% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 03-10-22 |
Jon Blaskovich
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 25-10-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 03-10-22 |
Gastón Ortega
BRD | Director/Board Member | - | 03-10-22 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.97% | 0 M€ | 0,00% | - | |
0.11% | 9 M€ | -.--% | - | |
0.06% | 676 M€ | +10,22% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 54,69 | -4,09% | 841 086 |
27-03-24 | 57,02 | +1,30% | 834 506 |
26-03-24 | 56,29 | +1,92% | 1 815 204 |
25-03-24 | 55,23 | -1,11% | 1 220 197 |
22-03-24 | 55,85 | -0,05% | 1 011 575 |
uitgestelde koers Nyse, 28 maart 2024 om 21:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-63,97% | 541 mln. | |
+9,30% | 45,97 mld. | |
+52,73% | 43,93 mld. | |
+7,13% | 42,34 mld. | |
-8,78% | 28,27 mld. | |
+18,66% | 27,18 mld. | |
-21,95% | 19,44 mld. | |
+14,62% | 13,83 mld. | |
+31,90% | 12,4 mld. | |
+4,44% | 11,45 mld. |